Global Pharma Leader Digitizes Entire Cleaning Validation Lifecycle with ValGenesis iClean
March 26, 2025 | Global pharma leader digitizes entire cleaning validation lifecycle with ValGenesis iClean, enhancing efficiency, compliance, and innovation across its global operations.
April
ValGenesis Launches the Next Generation of VAL™, Bringing Governed AI to the Validation Lifecycle
04/14/2026
ValGenesis unveils the next generation of VAL™ at INTERPHEX 2026, enhancing validation in life sciences with governed AI for streamlined processes.
March
ValGenesis Strengthens Presence in Japan with Validator K.K. Partnership
03/31/2026
ValGenesis partners with Validator K.K. in Japan to enhance digital validation and compliance for life sciences companies, aiming to support Pharma 4.0 initiatives.
LOTTE Biologics Implements ValGenesis e-Logbook Solution to Modernize QC Operations
03/17/2026
LOTTE Biologics implements ValGenesis e-Logbook to modernize QC operations, enhancing efficiency and compliance in their biopharmaceutical development and manufacturing processes.
February
ValGenesis to Showcase Process Lifecyle Suite at BioProcessing Summit Europe 2026
02/27/2026
ValGenesis to showcase its Process Lifecycle Suite at BioProcessing Summit Europe 2026, demonstrating digital validation for streamlined drug development and compliance. Visit Booth No. 35 for insights.
ValGenesis to Exhibit Smart GxP™ at 2026 ISPE Europe Annual Conference
02/27/2026
ValGenesis to showcase its AI-powered Smart GxP™ platform at the 2026 ISPE Europe Conference, highlighting strategies for modernizing validation and AI-enabled quality systems in pharmaceuticals.
ValGenesis to Join Industry Peers at 2026 ISPE San Francisco Vendor Night
02/26/2026
ValGenesis to showcase AI-enabled digital validation at ISPE San Francisco Vendor Night 2026. Meet industry leaders and explore innovations in life sciences at Table No. 55.
Leading CDMO Adopts ValGenesis to Support Robotic Manufacturing Expansion
02/18/2026
Leading CDMO adopts ValGenesis to replace paper logbooks, enhancing compliance and efficiency in robotic manufacturing expansion.
January
GAMP Services Chooses ValGenesis to Lead Its Shift to Digital Validation
01/28/2026
GAMP Services selects ValGenesis to digitize its validation processes, enhancing compliance and operational excellence across life sciences, and supporting global clients with innovative digital solutions.
Global Vaccine Manufacturer Selects ValGenesis to Digitalize Equipment Qualification and Computer System Validation
01/20/2026
Leading vaccine manufacturer partners with ValGenesis to digitalize equipment qualification and computer system validation, enhancing compliance, efficiency, and scalability across global operations.
November
ValGenesis Wraps Up Global ValConnect Innovation Day Series with Hyderabad Event
11/18/2025
ValGenesis concludes its global ValConnect Innovation Day series in Hyderabad, showcasing AI-driven digital validation solutions and their transformative impact on the life sciences industry.
ValGenesis Named “BioTechnology Innovator of the Year” in 2025 BioTech Breakthrough Awards
11/11/2025
ValGenesis wins 2025 BioTech Breakthrough Award for pioneering digital validation and AI-enabled lifecycle management in the life sciences sector.
October
ValGenesis to Showcase AI-Enabled Validation at 2025 ISPE Annual Meeting and Expo
10/22/2025
Discover how ValGenesis is revolutionizing life sciences validation with AI at the ISPE 2025, featuring live demos and exclusive insights from ARC Advisory Group.
September
ValGenesis Expands Global ValConnect Innovation Day Series with Frankfurt Event
09/26/2025
ValGenesis brings its innovative ValConnect series to Frankfurt, showcasing AI-driven digital validation advancements and facilitating dynamic discussions among life sciences leaders.
ValGenesis Announces First ValConnect Innovation Day 2025 in Princeton, NJ
09/09/2025
ValGenesis hosts ValConnect Innovation Day in Princeton, NJ, showcasing AI-driven advancements in digital validation for life sciences leaders.
July
Avance Clinical Strengthens Trial Integrity with ValGenesis
07/29/2025
Avance Clinical enhances trial integrity and efficiency with ValGenesis' digital validation platform, ensuring compliance and operational excellence in global clinical trials.
ValGenesis Secures $16 Million Strategic Financing to Accelerate Global Expansion and AI-Driven Innovation
07/22/2025
ValGenesis secures $16 million in strategic financing to drive global expansion and AI innovation in digital validation solutions for life sciences.
ValGenesis and CAI Partner to Advance AI-Enabled Digital Validation in Life Sciences
07/01/2025
ValGenesis and CAI partner to enhance AI-enabled digital validation in life sciences, modernizing processes, reducing manual effort, and improving compliance outcomes.
June
ValGenesis Launches Smart GxP™ as First AI-Enabled Platform to Unify Validation and Process Development
06/04/2025
ValGenesis launches the first AI-enabled platform, Smart GxP, to unify validation and process development, enhancing efficiency and compliance in the life sciences sector.
April
Scigeniq Accelerates Time to Value with 3-Month ValGenesis VLMS Implementation
04/01/2025
Scigeniq modernizes its processes with a swift 3-month implementation of ValGenesis VLMS, enhancing efficiency and compliance in digital validation.
March
ValGenesis to Unveil AI-Enabled Digital Validation at INTERPHEX 2025
03/27/2025
Discover ValGenesis' AI-enabled digital validation assistant, VAL, set to revolutionize speed, efficiency, and compliance in life sciences at INTERPHEX 2025.
Global Pharma Leader Digitizes Entire Cleaning Validation Lifecycle with ValGenesis iClean
03/26/2025
Global pharma leader digitizes entire cleaning validation lifecycle with ValGenesis iClean, enhancing efficiency, compliance, and innovation across its global operations.
ValGenesis VLMS Chosen to Simplify Validation Complexity for Major U.S. Healthcare Provider
03/11/2025
Major U.S. healthcare provider selects ValGenesis VLMS to streamline validation, achieve FDA compliance, and enhance operational efficiency across its network of medical institutions.
February
ValGenesis and Hitachi Industry & Control Solutions Announce Strategic Partnership
02/05/2025
ValGenesis and Hitachi Industry & Control Solutions partner to enhance digital validation for Japan's life sciences, accelerating drug development and regulatory compliance.
January
ValGenesis and Compliance Group combine strengths in Synergistic Partnership to Advance Quality Excellence
01/28/2025
ValGenesis and Compliance Group partner to accelerate digital validation and regulatory compliance in life sciences, enhancing quality excellence and operational efficiency.
ValGenesis iRisk Selected to Support Safer, Compliant Vaccine Production and Distribution in Brazil
01/21/2025
ValGenesis iRisk chosen by a key Brazilian institution to enhance vaccine production and ensure regulatory compliance, streamlining quality risk management across all operational domains.
ValGenesis Wins Gold in Brandon Hall Group’s Excellence in Technology Awards
01/14/2025
ValGenesis wins Gold in Brandon Hall Group’s Excellence in Technology Awards for their innovative video-based learning program, showcasing AI-generated audio and life-like human avatars.
ValGenesis Appoints Terrance Blackwell as Chief Delivery Officer
01/13/2025
ValGenesis Appoints Terrance Blackwell as Chief Delivery Officer
September
Rottendorf Pharma selects ValGenesis VLMS after a comprehensive review of digital validation solutions
09/23/2024
Rottendorf Pharma chose ValGenesis VLMS because of its capability to streamline and standardize processes coupled with the intuitive user interface of VLMS 5.0.
ValGenesis Appoints David Medina as Chief Marketing Officer to Spearhead Global Growth Strategy
09/03/2024
David joins ValGenesis with an impressive track record of driving marketing success across the enterprise SaaS, life sciences, and technology sectors.
July
ValGenesis and FrontWell Solutions Announce Strategic Alliance
07/23/2024
ValGenesis and FrontWell Solutions collaborate to empower life sciences organizations, driving excellence in manufacturing and validation.
ValGenesis and Pharmasys in Strategic Partnership to Enhance Compliance in European Life Sciences
07/16/2024
ValGenesis and Pharmasys are collaborating to enhance compliance processes in the European life sciences industry.
Rapidly Expanding Global CDMO Selects ValGenesis e-Logbook to Digitize Logbook Management Across Manufacturing Sites
07/09/2024
The company uses advanced nitrogen purging capabilities and is a state-of-the-art fill/finish CDMO specializing in sterile filling of vials, syringes, and cartridges for the biotech and pharmaceutical industries.
ValGenesis Announces Strategic Reseller Partnership with Validator K.K. to Expand in the Japanese Market
07/03/2024
Validator’s services solve a range of key issues within the pharmaceutical industry, making them a go-to partner in Japanese life sciences.
June
ValGenesis Successfully Showcased the Transformative Power of Its Platform Through New Product Announcements and Customer Case Studies at ValConnect 2024
06/26/2024
The ValConnect conference, in Lisbon was a great success, with an excellent line-up of new releases and customer success stories for partners, customers, and industry experts.
ValGenesis Announces Zamann as Service Partner for Europe
06/18/2024
ValGenesis and Zamann have partnered to provide customers in life sciences and other highly regulated industries across Europe.
ValGenesis and Celere Announce Strategic Partnership
06/11/2024
Célere partners with life sciences and healthcare institutions to help them improve operational performance and regulatory compliance through digitized cGMP facilities, cGxP CSV.
ValGenesis Unveils VLMS 5.0, Revolutionizing Digital Validation with Industry-First AI Innovation
06/04/2024
ValGenesis Inc. announced the launch of VLMS 5.0, the new version of its flagship digital validation lifecycle management software poised to transform the industry's approach to digital transformation.
May
ValGenesis and Autocal Announce Strategic Alliance
05/29/2024
ValGenesis and Autocal have strengthened their capabilities to assist life sciences companies in India meet stringent regulatory requirements for quality and safety in drug development
A Global Science and Technology Company Selects ValGenesis VLMS
05/14/2024
A global science and technology company selected ValGenesis VLMS to digitize the computer system validation process across its manufacturing sites.
ValGenesis to Host ValConnect 2024 Europe in Lisbon
05/07/2024
ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS) will unveil the next version of VLMS and an enhanced portfolio of cutting-edge solutions at ValConnect 2024 Europe, its annual European user conference to be held in Lisbon, Portugal.
ValGenesis Announces Adryan as New Service Partner for Europe
05/02/2024
ValGenesis and Adryan have strengthened their capabilities to assist life sciences companies meet stringent ISO, FDA, and EU regulatory requirements for quality and safety in drug development and manufacturing.
April
ValGenesis Announces DynaCompliance as Service Partner for US & India
04/24/2024
DynaCompliance helps life sciences companies integrate the latest digital technologies and data-driven approaches into drug development, manufacturing, and validation processes, through comprehensive compliance and validation solutions.
Leading Global Biotechnology Company Selects ValGenesis iRisk
04/16/2024
A pioneer in scientific research for complex and devastating diseases, the company is advancing a pipeline of potential critical drug therapies across neurology, neuropsychiatry, specialized immunology, and rare diseases.
ValGenesis and Billennium Announce Strategic Partnership
04/02/2024
Billennium will implement and manage the entire range of ValGenesis products including ValGenesis VLMS, the industry standard digital validation platform for life sciences worldwide.
March
ValGenesis Announces Contrader as New Implementation Partner for Italy
03/19/2024
ValGenesis partners with Contrader to offer innovative digital solutions for life sciences in Italy, combining expertise in validation and ICT to support Industry 4.0 transformation.
Multinational Biopharmaceutical Company Selects ValGenesis iRisk
03/12/2024
A multinational biopharmaceutical company selected ValGenesis iRisk for implementing the ICH Q14 framework on PAT analytical methods across its global manufacturing sites.
ValGenesis and CSols Inc., Partner To Optimize Laboratory Efficiency
03/05/2024
CSols and ValGenesis collaborating as an implementation partner and consultant for computer system validation (CSV).
February
ValGenesis and RxCloud Announce Strategic Partnership
02/13/2024
ValGenesis and RxCloud are on a mission to help life sciences companies meet the FDA, ISO, and GAMP regulatory requirements and standards for quality and safety in the drug development and manufacturing life cycle.
ValGenesis Announces Amaris Consulting as Service Partner for EU & LATAM
02/06/2024
Amaris Consulting provides high value-added technology services in the digital and information systems, telecommunications, life sciences and engineering fields for over 1,000 clients across the globe.
January
ValGenesis and Trinity Bridge Announce Strategic Partnership
01/30/2024
Trinity Bridge Professional Services LLC, a life sciences consulting firm in New England, have partnered to extend a suite of digital validation solutions from ValGenesis to help companies in the U.S. respond rapidly to increasingly dynamic environments.
ValGenesis Announces Performance Validation as New Service Partner
01/23/2024
In this partnership, Performance Validation will implement and manage next-generation digital validation tools developed by ValGenesis, including ValGenesis VLMS and VLMS Express, a simplified cloud-based digital validation solution for startups and midsized companies.
ValGenesis and MMR Consulting Announce Strategic Partnership
01/16/2024
MMR Consulting will implement and support the ValGenesis product suite, including ValGenesis VLMS, and VLMS Express, a simplified cloud-based validation solution for organizations that need to start small and deploy and scale quickly
ValGenesis and GMP Pros Announce Strategic Partnership
01/10/2024
ValGenesis and GMP Pros aim to help customers solve their most complex process challenges and meet their digital compliance obligations through a suite of versatile products from ValGenesis.
Leading Spanish Pharmaceutical Company Selects ValGenesis VLMS
01/02/2024
Founded in Spain over eight decades ago, the company focuses on developing over the counter (OTC) drugs and products. Since then, it has grown its production to include prescription (RX) drugs and launched its first generic product on the Spanish market.
December
ValGenesis and Medhini Group Announce Strategic Partnership
12/20/2023
ValGenesis and Medhini are working to enable customers with robust manufacturing intelligence solutions from ValGenesis – VLMS, iRisk, Process Manager, Process Insight, and e-Logbook.
AmplifyBio Goes Live with ValGenesis VLMS for Digital Transformation in Validation Processes
12/12/2023
AmplifyBio is growing rapidly in the pursuit of creating the leading technology-integrated service organization for the commercialization of advanced therapies.
ValGenesis and Acumen Analytics Announce Strategic Partnership
12/07/2023
Acumen Analytics, a leader in intelligent digital transformation, have partnered to provide advanced risk management solutions for life sciences companies.
Top 5 Global Cell and Gene Therapy Manufacturer Selects ValGenesis
12/05/2023
ValGenesis digital validation platform was chosen to enhance their global validation processes, underscoring its commitment to elevating CAR-T therapy production standards.
November
A Global Leader in Animal Health Selects ValGenesis VLMS
11/21/2023
ValGenesis will provide technology transfer services and streamline multiple processes at the company’s manufacturing site in Brazil that produces a high-volume commercial product.
ValGenesis Announces Soluciones GXP as New Service Partner for LATAM
11/14/2023
ValGenesis VLMS product suite alongside Soluciones GXP’s immense regulatory expertise across the life sciences sector in Latin America (LATAM).
Global Full-Service CRO Selects ValGenesis VLMS
11/07/2023
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a UK-based global full-service contract research organization (CRO), selected ValGenesis VLMS to digitize its corporate validation process.
October
US Government Contractor Selects ValGenesis VLMS
10/31/2023
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a US government contractor selected ValGenesis VLMS to digitize its corporate validation process.
Canadian Biotech Company Selects ValGenesis VLMS
10/25/2023
Canadian biotechnology company selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize its corporate validation process.
ValGenesis Launches New Training Platform ValGenesis University
10/19/2023
ValGenesis University marks a significant milestone in our unwavering commitment to customer success, enhancing the value of our customers' investments.
ValGenesis Presents Impressive Series of Innovations at ValConnect 2023
10/17/2023
ValGenesis successfully concluded its annual user conference on Thursday, September 28th, having presented an impressive series of product innovations for 2024 to customers, partners, and industry experts.
ValGenesis and Brevitas Announce Strategic Partnership
10/12/2023
Brevitas serves global leaders in the pharmaceutical, biopharmaceutical, biotechnology, medical devices, chemical, and food and beverage industries since 2010.
ValGenesis Announces Strategic Partnership with Valspec
10/10/2023
Valspec is the leading provider of computer system validation and system lifecycle (SLC) services including the testing, commissioning, and qualification of manufacturing automation and IT systems.
September
ValGenesis Announces Astrix as Validation Partner
09/26/2023
ValGenesis and Astrix are both innovators, with compliance forming the heart of their solutions. Combining their extensive experience to ensure that customers get the optimal validation experience from ValGenesis products, the companies will drive digital transformation programs for life sciences companies, helping them unlock their full potential and meet stringent digital compliance obligations.
ValGenesis Announces Scigeniq as New Service Partner for MENA
09/19/2023
ValGenesis and Scigeniq have decades of experience with some of the world’s largest and best-known life sciences companies, streamlining and optimizing their manufacturing processes.
ValGenesis Revolutionizes Risk Management with New iRisk Tool Sets
09/12/2023
ValGenesis iRisk emerges as the vanguard of next-generation risk management platforms, converging all risk-related imperatives into a unified ecosystem.
Arizona Automation & Technologies Partners with ValGenesis
09/05/2023
As a service partner, Arizona Automation & Technologies will provide implementation services for a suite of ValGenesis products, including VLMS Express.
August
ValGenesis and AUSTAR Group Announce Strategic Partnership
08/16/2023
ValGenesis and AUSTAR implemented ValGenesis iRisk at two large drug manufacturing centers in China, strengthening compliance across their operations.
June
Global Biotechnology Company Selects SaaS-based ValGenesis VLMS
06/27/2023
Global Biotechnology Company Selects SaaS-based ValGenesis VLMS To Digitalize Validation Lifecycle Processes
ValGenesis and Radiant Digital Announce Strategic Partnership
06/20/2023
ValGenesis and Radiant Digital PTE Ltd. are poised to deliver future-ready solutions that can completely transform a company's IT systems and applications, infrastructure, and workforce.
ValGenesis and PharmEng Technology Announce Partnership
06/06/2023
ValGenesis’ platform, which includes its flagship VLMS offering, helps the world’s leading life sciences companies enable compliance and enforce standardization with 100% digital, risk-based validation software.
May
ValGenesis and Life Science Consulting Pvt. Ltd. Form Partnership
05/30/2023
ValGenesis and Life Science Consulting Pvt. Ltd. will expand technical and regulatory support to customers through a network of experts across the globe, delivering new levels of digital collaboration, data integrity, risk management, and quality and compliance across validation lifecycle processes.
Leading Pharmaceutical Company in Brazil Chooses ValGenesis iRisk to Redefine and Automate Risk-Based Validation Processes
05/23/2023
Leading pharmaceutical company in Brazil selected ValGenesis iRisk to redefine and automate the company’s risk-based validation processes.
ValGenesis and KVS Technologies Partner to Drive Digital Transformation
05/16/2023
KVS Technologies is highly proficient in computer system validation (CSV), and regulatory intelligence and compliance services, helping companies stay current and compliant with 21 CFR Part 11 and EU Annex 11 regulations.
Elite Biotechnology Company Selects ValGenesis VLMS
05/09/2023
An elite biotechnology company selected ValGenesis VLMS for digitizing multiple validation processes across the organization. The company selected ValGenesis VLMS after a rigorous audit of solutions.
ValGenesis and MEPHARMA partner to serve companies across UAE/MENA
05/02/2023
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and MEPHARMA, a strategic regulatory consulting services company, have partnered to provide a range of regulatory intelligence, compliance, and validation and automation solutions for companies in the United Arab Emirates (UAE) and the Middle East and North Africa (MENA).
April
ValGenesis unveils Process Manager for Digital Cleaning Validation
04/25/2023
ValGenesis Process Manager is designed to eliminate these commonly cited observations by digitizing, automating, and controlling the end-to-end cleaning validation lifecycle, all aligned to the FDA's lifecycle approach for cleaning validation.
ValGenesis and VTI Life Sciences Announce Strategic Global Partnership
04/11/2023
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and VTI Life Sciences (VTI), a leader in the field of commissioning, qualification, and validation (CQV) as well as automation services, have partnered to provide pharmaceutical, biotechnology and medical device manufacturers a full range of validation, automation, and quality systems services for their cGMP/GLP facilities.
ValGenesis and ProQuality Network to Deliver Quality & Compliance Solutions
04/04/2023
ValGenesis and ProQuality Network are helping companies evaluate digital transformation solutions in line with Pharma 4.0 requirements with special focus on quality and compliance.
March
ValGenesis Launches Design Manager, the Industry's First CSA-Ready System
03/21/2023
ValGenesis Design Manager, a new module within VLMS 4.2 that is ready for computer software assurance (CSA) out of the box. As a new module within VLMS 4.2, Design Manager enables any company to develop risk-based requirements and apply critical thinking to validation processes.
Continuus Pharmaceuticals Embraces Digital Validation
03/14/2023
ValGenesis, Inc., the market leader in enterprise validation lifecycle management solutions, announced that Continuus Pharmaceuticals, an end-to-end integrated continuous manufacturing (ICM) company, successfully went live with the ValGenesis Validation Lifecycle Management System (VLMS) to efficiently manage validation processes across the company as 100% digital.
February
ValGenesis & Rephine partner to offer Life Sciences Compliance Solutions
02/28/2023
The strategic alliance will offer global pharmaceutical companies a streamlined, software-based solution to enhance quality assurance across their global supply chains.
ValGenesis and Enterey Partner to Deliver Better Consulting Experience
02/21/2023
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and Enterey, a specialist life sciences consulting company, have partnered to deliver Pharma 4.0-focused digital transformation services and solutions for life sciences companies across the U.S.
ValGenesis and Scignyte to Drive Digital Transformation Across Asia
02/07/2023
ValGenesis and Scignyte provide an integrated governance approach with streamlined collaboration and data integrity, further strengthening risk and compliance across R&D processes.
January
Leading Pharmaceutical Manufacturer Selects ValGenesis VLMS for CSV
01/17/2023
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced that a leading pharmaceutical manufacturer selected ValGenesis VLMS to digitize multiple validation processes across the organization after a rigorous audit of possible solutions.
ValGenesis and QualiTech to provide Digital Validation Services in Greece
01/10/2023
In this partnership, QualiTech will implement and manage next-generation digital validation tools developed by ValGenesis, enabling clients to further strengthen risk and compliance across the GMP lifecycle.
December
ValGenesis and Verista Partner to Deliver Digital Validation Services
12/19/2022
“Digitizing validation processes is crucial for compliance-focused life sciences companies to be able to meet stringent global regulatory requirements,” says Dr. Siva Samy, CEO & Chief Product Strategist at ValGenesis.
ValGenesis and Orbis Partner To Serve Life Science Companies in Europe
12/13/2022
ValGenesis, Inc and Orbis LabSystems have partnered to deliver best-in-class digital validation solutions for life science companies across Europe, with a focus on Ireland.
Global Biotechnology Company Selects ValGenesis’ SaaS Platform
12/06/2022
ValGenesis VLMS enforces standardization and compliance with 100% digital, risk-based validation software that integrates easily with any business system. This leads to significant gains, better monitoring, and adequate utilization of systems.
November
ValGenesis and LifeBee partner to serve life science companies in Europe
11/28/2022
ValGenesis, Inc and LifeBee have partnered to deliver best-in-class business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance, laboratories, logistics, serialization, regulatory affairs and pharmacovigilance for biopharmaceutical, medical devices, and nutraceutical companies across Italy and Switzerland.
Global Medical Diagnostics Company Selects SaaS-based ValGenesis VLMS
11/01/2022
The company is building out a new, GMP-compliant facility for a new fermented product being brought to market. The company will implement the VLMS for equipment qualification and use ValGenesis e-Logbook for continuous monitoring of the equipment at their new facility.
October
ValGenesis Launches VLMS Express for Small/Midsize Life Sciences Companies
10/18/2022
“Implementing a digital validation lifecycle management solution as soon as a company opens its doors is rare. But we increasingly find that new age life sciences startups are determined to leverage digital automation and other smart factory capabilities from the outset,” says Dr. Siva Samy, CEO at ValGenesis.
Hundreds of attendees participate in ValGenesis’ ValConnect!
10/18/2022
ValGenesis CEO and Chief Product Strategist Dr. Siva Samy kicked off this year’s conference with an overview of 2022 and the product roadmap for 2023 and beyond.
September
ValGenesis announces partnership with QbD Pharmaceutical Services
09/30/2022
In this partnership, QbD Pharmaceutical Services will implement and manage next-generation digital risk management, process validation verification tools developed by ValGenesis, enabling clients to further strengthen quality by design and process validation and verification across the GMP lifecycle. Both companies are working to release the full potential of digital transformation for clients, providing them with the best course for success in the new digital validation landscape.
ValGenesis and Xevalics Consulting to Serve Companies across the U.S.
09/13/2022
ValGenesis, Inc and Xevalics Consulting have partnered to deliver best-in-class digital validation solutions for the life sciences industry across the U.S.
ValGenesis Announces Impressive Speaker Lineup for ValConnect
09/09/2022
ValGenesis Inc. announces the final speaker lineup of ValConnect 2022, its annual user conference that runs from Monday, September 26th through Wednesday September 28th.
July
ValGenesis and EIS Partner to serve companies across the US and Europe
07/19/2022
ValGenesis, Inc and Enhanced Information Solutions (EIS) have partnered to deliver best-in-class digital validation solutions for the life sciences industry across the U.S. and Europe.
June
ValGenesis Acquires 4Tune Engineering, Extends Product Portfolio
06/14/2022
The acquisition was initiated when ValGenesis leadership saw the strategic product synergy for customers requiring a complete and more integrated platform across the validation lifecycle focusing on Pharma 4.0.
European Multinational Consumer Goods Company Selects ValGenesis VLMS
06/03/2022
This is the largest consumer goods company based in the U.K. to implement ValGenesis VLMS. The system will drive all the company’s validation programs, including computer system validation (CSV) and equipment qualification.
May
Top 5 Global Life Sciences Company Goes Live with ValGenesis e-Logbook
05/03/2022
Cloud-based ValGenesis e-Logbook is Part 11/Annex 11 compliant, built for security-sensitive facilities with restricted network access, and scalable to thousands of users across multiple global sites to enforce consistency and data integrity in all logbook processes.
April
ValGenesis and Zenovative Partner to Modernize and Digitize Validation
04/26/2022
By combining Zenovative’s expertise with ValGenesis’ validation lifecycle management software, pharmaceutical companies can implement their digitization plans in accordance with the standards of Industry 4.0.
ValGenesis Releases Standalone Cloud-based Electronic Logbook Application
04/13/2022
Cloud-based ValGenesis e-Logbook is Part 11/Annex 11 compliant, built for security-sensitive facilities, and can scale to thousands of users across multiple global sites.
ValGenesis Reports Exceptional Fiscal Year Performance
04/06/2022
ValGenesis’ proven enterprise validation lifecycle management platform currently supports more than 300 sites and 35,000 GxP systems and is used by 30 of the world’s top 50 life sciences companies.
March
ValGenesis and ZeeDimension Partner to Serve the Middle East
03/01/2022
As part of the partnership, ZeeDimension offers the implementation and management of next generation digital validation tools developed by ValGenesis, further strengthening risk and compliance processes. Through ValGenesis, ZeeDimension will serve a wider network of pharmaceutical companies across the globe.
February
Modis and ValGenesis Partner To Serve Italian Pharmaceutical Industry
02/17/2022
ValGenesis partners with Modis to bring best-in-class digital validation solutions to its clients.
French Pharmaceutical Company Selects ValGenesis VLMS
02/14/2022
The company, which markets its drugs in over 100 countries, applied sophisticated evaluation criteria that matched vendor capabilities with their demanding business needs. At the end of the process, ValGenesis VLMS was the clear winner.
January
Leading Italian Pharmaceutical Company Chooses ValGenesis VLMS
01/18/2022
ValGenesis’ latest customer in Italy develops pharmacological solutions for cardiovascular diseases, oncology, and anti-infectives.
November
ValGenesis Launches New Brand Identity to Strengthen Company Positioning
11/16/2021
ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), is proud to announce its new corporate brand identity and redesigned logo. The new design system better reflects the company’s values and positions it for new levels of growth.
October
Steve Reynolds Joins ValGenesis as Chief Revenue Officer
10/11/2021
ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Steve Reynolds as Chief Revenue Officer. Steve will oversee revenue growth through his leadership of the sales team as well as development of new growth strategies.
ValGenesis appoints Mike Hicks as Chief Technology Officer
10/04/2021
ValGenesis appoints Mike Hicks as Chief Technology Officer. "I am incredibly excited to join a clear market leader and to be part of the innovative leadership team at ValGenesis.
ValGenesis appoints Bo Olsen, as Head of European Operations
10/01/2021
ValGenesis, Inc., announced the appointment of Bo Olsen as Head of European Operations. Bo will be in charge of developing business opportunities and expanding ValGenesis's operation in the European region.
September
ValGenesis Inc., Announces New VP of Marketing to Join its Executive Team
09/09/2021
ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin Potts as Vice President of Marketing, effective August 1, 2021.
August
Global Top 10 pharmaceutical company implements ValGenesis eLog
08/24/2021
One of the top ten global pharmaceutical companies selected ValGenesis’ eLog solution to meet its global needs for the digitization of logbooks.
ValGenesis Inc. Announces Kevin O’Donnell as Chief Financial Officer
08/02/2021
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin O’Donnell as Chief Financial Officer, effective August 2, 2021.
June
Top Italian Life Sciences Company selects ValGenesis’ SaaS platform
06/15/2021
A top Italian life sciences company has chosen to implement ValGenesis’ 100% paperless Validation Lifecycle Management System (VLMS) to manage its corporate validation lifecycle process.
May
Morgan Stanley Expansion Capital Invests $24 Million in ValGenesis
05/04/2021
Digitization of backend processes and workflow automation is a rapidly emerging area of growth for healthcare and life sciences companies. As a market leader, ValGenesis offers a fit-for-purpose platform for validation lifecycle management, resulting in significant cost and time efficiencies for global, compliance focused organizations.
January
American Cell Therapies Company Selects ValGenesis VLMS
01/25/2021
A U.S. based cell therapies company has selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize multiple corporate validation lifecycle processes across the organization.
International biosciences company selects ValGenesis VLMS
01/20/2021
An international biosciences company has selected ValGenesis to digitize the validation processes for its products and solutions through a single instance of ValGenesis VLMS with multilingual support that would be accessed by thousands of life science organizations across 40 countries.
Pioneering Gene Therapy Company Selects ValGenesis’ SaaS Platform
01/06/2021
A pioneering gene therapy company has selected ValGenesis VLMS for its remote validation capability, and for its ability to enable efficient change and risk management to help the company achieve better control over these processes.
December
ValGenesis VLMS drives digital transformation at Biocon Biologics
12/14/2020
The scalable and configurable nature of ValGenesis VLMS will enable Biocon Biologics’ quality leaders to monitor the validation status of their instruments, equipment, software systems, and processes remotely and in real time across multiple sites.
Global Medical Devices Company Went Live With ValGenesis VLMS
12/07/2020
ValGenesis VLMS enables remote validation execution, preventing interruptions in the company’s validation programs especially in these times when their workforce is predominantly remote and/or working from home. The system is configurable and scalable to facilitate implementation at a single site and expansion across multiple sites in the future.
November
Global Top 5 life science organization selects ValGenesis VLMS
11/17/2020
A global Top 5 life science organization has chosen ValGenesis VLMS for its depth of functionality and ability to meet all the company’s business needs. ValGenesis will manage the validation of the company’s Labs with initial deployment across two sites.
October
Global Clinical-stage Biopharmaceutical Company Selects ValGenesis VLMS
10/27/2020
ValGenesis VLMS will help the company achieve more efficient change control management across their IT Business systems, and enable control and flexibility in assigning and managing the various validation activities.
Top 10 US-based Injectable Company Selects ValGenesis VLMS
10/19/2020
A Top10 US-based injectable company selects ValGenesis VLMS – a single, end-to-end, digital validation solution that can enable a single source of truth, thereby ensuring data integrity and adherence to all regulatory requirements.
Dr. Reddy’s Laboratories goes paperless in validation with ValGenesis VLMS
10/05/2020
ValGenesis VLMS, a 100% paperless validation lifecycle management system, incorporates electronic document and process workflows, electronic signatures, with requirements tracking and test protocol integration which helps accelerate the validation process while guaranteeing an integrated approach to risk, thereby enabling stringent data integrity governance and regulatory compliance.
September
Global Pharma Giant Goes Paperless with ValGenesis VLMS
09/21/2020
ValGenesis digitized and standardized the company’s validation process and is further expanding the system across the company’s sites in the U.S., Germany and Japan.
U.S. Federal Government Agency Goes Paperless With ValGenesis VLMS
09/10/2020
By automating their corporate validation process, ValGenesis VLMS has enabled significant efficiency gains, including a reduction in the validation cycle time, enabling data integrity governance, improving regulatory compliance, and providing a holistic view of real-time validation status of GxP systems and processes across the agency.
ValGenesis Deploys Augmented Reality Solution for Hands-Free Validation
09/08/2020
ValGenesis Inc., a market leader in paperless validation solutions, has announced that its Validation Lifecycle Management System (VLMS) supports Augmented Reality (AR) for remote and hands-free validation, to improve efficiency, data integrity, and compliance in the corporate validation process.
July
Global Nutraceutical Giant Implements SaaS-based ValGenesis VLMS
07/15/2020
The ValGenesis VLMS provides real-time validation status of the company’s equipment and GxP systems and processes across its sites and is helping them easily create and maintain traceability matrices during the CSV process.
ValGenesis and Ambit-BST announce strategic partnership
07/13/2020
ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), has announced a strategic partnership with Ambit-BST, a digital technology specialist company offering specialized solutions and services related to information technology (IT) for life science companies. The partnership will offer 100% paperless validation solutions for regulated life science companies across Spain and Latin America.
Fast Growing Biopharmaceutical Company Chooses ValGenesis VLMS
07/08/2020
A fast growing research based biopharmaceutical company has chosen the ValGenesis Validation Lifecycle Management System (VLMS), an electronic, end-to-end SaaS-based system to digitize and standardize the computer system validation (CSV) process across the organization.
Top 5 Global Life Sciences Giant Goes Live With ValGenesis VLMS
07/06/2020
The ValGenesis VLMS has enabled a single source of truth and standardized validation processes across this company’s multiple global sites, resulting in huge process and operational efficiencies.
June
Japanese global pharma giant selects SaaS-based ValGenesis VLMS
06/29/2020
The company’s users were impressed that despite ValGenesis VLMS’s wide-ranging functionalities, it is incredibly easy to use and significantly saves time in executing multisite validation processes.
March
Largest European Life Science Organization Selects ValGenesis VLMS
03/30/2020
The global life science player sees ValGenesis VLMS as the most powerful end-to-end paperless validation solution that can support remote management of validation activities and enable standardization of validation processes across global sites, with adherence to data integrity governance and global regulatory standards.
German Subsidiary of Global ICT Company Chooses ValGenesis VLMS
03/17/2020
The company chose the ValGenesis VLMS based on its comprehensive functionality and quality risk management approach that would augment the company’s GMP standards.
FDC ARDL’s Digitized CSV Process Goes Live With ValGenesis VLMS
03/10/2020
ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions, announced that the digitized Computer System Validation process went live at FDC ARDL (Analytical Research Development Limited), driven by ValGenesis’s cloud-based Validation Lifecycle Management System (VLMS).
ValGenesis opens new offices in Mississauga, Canada and Long Beach, CA
03/04/2020
ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions announced the opening of two new offices in Mississauga, Canada and Long Beach, CA expanding its presence to accommodate rapid growth across North America.
Leading T-cell immunotherapy company selects ValGenesis VLMS
03/02/2020
Comprehensive and easily configurable, the VLMS is a cloud-based, SaaS, end-to-end validation lifecycle management system with powerful collaborative, risk-based, and change management functionalities that enable swift and audit-ready processes at enterprise level.
February
Global CDMO Selects ValGenesis VLMS to Digitize Validation
02/11/2020
The company was impressed by many proven case studies on the ValGenesis VLMS’s ability to significantly reduce validation cycle time while enabling audit-ready processes.
January
Global Integrated Pharmaceutical Company Selects ValGenesis VLMS
01/31/2020
After evaluating multiple validation software solutions available in the market, the company selected ValGenesis VLMS – a single, end-to-end solution that can manage the entire validation lifecycle process.
December
Global Biopharmaceutical Company Chooses ValGenesis VLMS
12/17/2019
Today, in addition to the scope of automating and managing this company’s EQ, CSV, cleaning and process validation lifecycle processes, ValGenesis will enable a robust prediction and intelligence forecasting mechanism through the VLMS.
An Agency of the U.S. Federal Govt selects ValGenesis VLMS
12/10/2019
Facing inefficiencies and delays in a paper-based validation approach, the company evaluated and selected ValGenesis's VLMS - a cloud-based SaaS solution to manage its validation lifecycle, to meet stringent regulatory standards in the biomedical industry.
November
Icelandic Biotech Firm chooses ValGenesis VLMS
11/26/2019
With robust flexibility, web services, and scalability tools built into the core solution, ValGenesis's VLMS easily integrates with other software systems to provide seamless, end-to-end validation lifecycle management.
Global Healthcare Company goes live with ValGenesis VLMS
11/19/2019
Describing ValGenesis's end-to-end validation lifecycle management system with comprehensive risk management, trace matrix, and change management functionalities as "powerful," the company has digitized their CSV process through ValGenesis VLMS and plans to expand its use to a 100% paperless process for equipment validation soon.
October
ValGenesis and T-Systems to enable Digitization through IIoT Solutions
10/29/2019
ValGenesis, Inc., announced a technology partnership with T-Systems North America in its effort to help the Life Science sector's transformation to Industrial Internet of Things (IIoT) Technology, which is becoming extremely critical in pharmaceutical and biotech manufacturing where sub-optimal environmental conditions have often lead to noncompliance.
Soft gelatin capsules manufacturer chooses ValGenesis VLMS
10/08/2019
Keen to start creating leaner, more efficient Computer System Validation (CSV) processes, the company had evaluated multiple solutions before selecting ValGenesis Enterprise VLMS—a cloud-based SaaS solution that enables rigorous compliance, improves process consistency, facilitates standardization and significantly reduces validation cycle time.
ValGenesis Establishes New Subsidiary ValGenesis Canada Inc., Toronto
10/01/2019
ValGenesis has aggressively expanded its presence globally, successfully forging partnerships with several life science companies, helping them migrate from manual paper-based validation processes to 100% paperless validation. The new subsidiary in Canada will further accelerate and support this growth by providing a strategic vantage point for engagement with the region’s largest pharmaceutical and life science companies.
June
ValGenesis releases eLog management solution
06/18/2019
The ValGenesis eLog extends plant floor automation by managing and tracking equipment use, cleaning status, maintenance and calibration records with an easy to use mobile App with support for commonly used tablets such as iPad and Android devices. Users can capture the logs through mobile devices by simply scanning the QR code available at the equipment, instruments and clean rooms, with or without network connectivity.
May
ValGenesis opens new office in Munich
05/14/2019
ValGenesis’s decision to open an office with local talent in Munich was based on increasing global demand for and adoption of its electronic Validation Lifecycle Management System. We’ve already had thousands of users working with our VLMS as a system of record across Europe, some as far back as 2010.
April
ValGenesis launches VConnect
04/09/2019
VConnect addresses manual data entry issues that contribute to data integrity concerns by seamlessly supporting RS232 or TCP/IP interface protocols. For complex instruments, VConnect automatically captures original files generated by the instrument software and, if modified (via instrument software), VConnect captures and versions these file(s).
ValGenesis Sets New Standard for Tablet-Based Validation Execution
04/03/2019
"With the increased use of tablets and the need to continue working even when the connectivity is not available, we realized the benefits of offering a mobile app for ValGenesis VLMS to support use of tablets for validation activities,” said Dr. Siva Samy, CEO & Chief Product Strategist of ValGenesis, Inc.
March
FDC Chooses ValGenesis VLMS to Digitize Corporate Validation Process
03/29/2019
“We are happy that our search for a 100% paperless validation solution has finally ended,” says Dr. Rupesh Kelaskar, Head of Corporate Quality Control. “It is time to make the move to paperless validation through a cloud-based electronic system such as ValGenesis VLMS, which enables rigorous compliance, improves process consistency, provides standardization and significantly reduces validation cycle time.”
Leading Global R&D-Based Pharma Company Chooses ValGenesis VLMS
03/06/2019
The configurable nature of ValGenesis VLMS helps global companies implement at a single site or process, and its scalability makes it easy to expand globally.
February
World’s Largest Pharmaceutical Company Selects ValGenesis VLMS
02/12/2019
To harmonize and standardize the validation process at the enterprise level, this pharma giant decided to go paperless in their validation process for equipment, process, cleaning and method after realizing traditional, manual, paper-based validation processes were proving both costly and inefficient.
January
Contract Pharmaceutical Drugs Manufacturer Chooses ValGenesis VLMS
01/29/2019
ValGenesis VLMS is an ideal solution for companies like this, interested in reducing overall validation time while realizing significant cost savings. Now these companies can focus on what they do best, while leaving the rest to ValGenesis VLMS.
World’s Leading ORS Manufacturer Chooses ValGenesis VLMS
01/08/2019
ValGenesis VLMS is a best-in-class software solution that offers all the benefits of an electronic system with necessary controls that adhere to global compliance needs, which is appealing to more and more global life science companies, such as this client.
December
World’s Leading Infusion Therapy Company Chooses ValGenesis VLMS
12/19/2018
The company conducted a detailed evaluation process of multiple solutions and selected ValGenesis Enterprise VLMS— an electronic, paperless solution that well meets all the organization’s validation lifecycle needs.
Global Nutraceutical Company Goes Paperless with ValGenesis VLMS
12/05/2018
ValGenesis VLMS is a state-of-the-art solution that complies with the company's current validation process while providing significant efficiency gains that greatly reduces validation cycle time, increases the standard of data integrity, improves regulatory compliance, and provides a holistic view of real-time validation status of their GxP systems and processes across the organization.
November
Global Life Sciences Company To Roll Out ValGenesis VLMS 4.0
11/27/2018
Traditional validation activities with paper-based validation processes stifle innovation, cause compliance risks and compromise life science firms’ ability to bring products to market on time. ValGenesis helps all regulated manufacturing companies to manage the validation process electronically, reduce validation cycle time, and enforce consistency and compliance in the corporate validation process.
Second Largest Pharma Company in Japan Chooses ValGenesis VLMS
11/06/2018
With ValGenesis Enterprise VLMS, the company will significantly reduce validation cycle time, gain a higher standard of data integrity, improve its regulatory compliance process, and gain a holistic view of real-time validation status across its regulated systems, thereby improving the quality and speed of the entire process.
Leading Biotechnology Company selects ValGenesis VLMS
11/01/2018
Recognizing that traditional, manual, paper-based validation processes are costly and inefficient, the company selected ValGenesis Enterprise VLMS—an electronic, paperless solution that well meets all its validation lifecycle needs.
October
ValGenesis Releases Next Generation VLMS 4.0
10/30/2018
ValGenesis, Inc., announced that it had released Version 4.0 of its 100% paperless Validation Lifecycle Management System (VLMS) that currently manages validation lifecycle processes for life science companies across the globe. ValGenesis, Inc. continues to work actively with clients to consistently incorporate their feedback to continually enhance user experience, real-time collaboration, data integrity, risk assessment and compliance adherence processes.
Global Leader in Genomics Chooses ValGenesis VLMS
10/08/2018
ValGenesis VLMS comes with multi-site and multilingual capabilities to standardize the validation process across a global organization.
World’s 6th-largest Independent Biotech Company Chooses ValGenesis VLMS
10/01/2018
With ValGenesis Enterprise VLMS, the company will significantly reduce validation cycle time, gain a higher standard of data integrity, improve its regulatory compliance process, and gain a holistic view of real-time validation status across its regulated systems, thereby improving the quality and speed of the entire validation process.
August
NNIT and ValGenesis Partner on Cloud-Based IT Validation Software
08/15/2018
The cloud-based ValGenesis solution helps life sciences companies eliminate the use of paper and remove the inefficiencies that plague today’s IT validation processes. It enables rigorous compliance, helps to address data integrity concerns, improve consistency and reduce validation cycle time significantly.
Global Life Sciences Company Selects Cloud-based ValGenesis VLMS
08/09/2018
ValGenesis offered a significant improvement to their current validation process. The opportunity to increase efficiency, reduce validation lifecycle times, improve regulatory compliance and gain a holistic view of site validation status, made ValGenesis their system of choice.
June
Dohmen Life Science Services Goes Paperless With ValGenesis VLMS
06/08/2018
DLSS selected ValGenesis Enterprise VLMS thus giving DLSS the ability to significantly improve their validation process through increased efficiency, a higher standard of data integrity, reduced validation cycle times, improved regulatory compliance, and a holistic view of real-time validation status for all regulated systems across the organization.
May
ValGenesis and PharmOut Announce Partnership for Paperless Validation
05/18/2018
This new partnership offers a cost-effective and innovative validation solution to Australian companies. Combining the expertise of PharmOut’s large team of validation consultants with the ValGenesis Validation Lifecycle Management System will deliver faster, cheaper validation services in Australia. It will also deliver all the advantages a paperless system offers, making Australian manufacturers more competitive in global markets.
Dr. Ajaz Hussain in 2018 Power List of Top 100 Inspirational Professionals
05/15/2018
Dr. Ajaz Hussain has once again been recognized for his contributions as one of the top 100 inspirational industry professionals by the Medicine Maker magazine under the Industry Influencer category. This is the third time Dr. Hussain has been selected for this recognition.
ValGenesis Establishes New Subsidiary ValGenesis EMEA in The Netherlands
05/10/2018
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced the opening of its new subsidiary in Netherlands to support the company’s expansion into key European markets and provide on-the-ground sales and customer support for current clients, prospects and partners in the region.
Top 10 Global Pharmaceutical Company Implements ValGenesis VLMS
05/08/2018
The flexibility of ValGenesis’ automated workflows, forms designer and process designer platform will make Validation, Risk Assessment and Change Management processes easier while significantly reducing the time it takes to accomplish these tasks. Furthermore, the system enables compliance and standardization across the entire organization whilst enforcing good document practices and ensuring data integrity.
January
To further enable digitization, Infosys Partners with ValGenesis
01/04/2018
Infosys’ Life Sciences Practice works with 50+ leading pharmaceutical and medical devices companies, providing premium regulatory, quality and compliance services. Infosys will deploy the ValGenesis Validation Lifecycle Management System (VLMS) to its customers as a single “paperless” system that manages every activity in the entire validation lifecycle.
September
ValGenesis Announces Strategic Partnership with VTI Life Sciences
09/19/2017
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce the strategic partnership with VTI Life Sciences (VTI). This partnership enables VTI to provide clients with validation services using the latest technology available in the ValGenesis VLMS system.
Dr. Ajaz Hussain Joins ValGenesis Board of Directors
09/12/2017
Dr. Ajaz Hussain brings a wealth of international pharmaceutical regulatory and business experience to ValGenesis, including his decade-long tenure with the United States Food and Drug Administration (US FDA), Center for Drug Evaluation and Research (CDER).
August
USPTO Grants ValGenesis First Patent on Paperless VLMS
08/22/2017
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS), is pleased to announce the issuance of a patent on paperless validation, #9,720,687. The patent granted by the U.S. Patent and Trademark Office (USPTO) focuses on ‘Validating and Maintaining Respective Validation Status of Software Applications, Manufacturing Systems and Business Processes’.
March
Global Medical Device Manufacturer Presents Case Study on ValGenesis VLMS
03/29/2017
ValGenesis, Inc., announced that a globally renowned Medical Device manufacturer will be presenting a case study about their experience with the paperless validation process. In the study, the medical device manufacturer explains how the paperless validation process helped to improve upon their efficiency while also standardizing the validation process across their sites.
June
World’s leading Medical Technology Company Implements ValGenesis VLMS
06/14/2016
Accessing ValGenesis VLMS through the enterprise-ready validated ValGenesis Cloud, allows companies to implement and deploy the system rapidly with less investment and in a shorter period of time.
May
Leading Healthcare Technology Company Implements ValGenesis VLMS
05/30/2016
ValGenesis VLMS provides a holistic view of the Validation process throughout the company with validation activities accessible in real-time from a convenient dashboard within ValGenesis. VLMS provides a direct line to validation tasks, inventory, work in progress, calendars, projects, reports, and a 360-degree view of GxP systems and assets by site.
ValGenesis Collaborates with Leading Plasma-based Product Company
05/17/2016
ValGenesis opened a new avenue of opportunity with a leading Plasma based product company that has implemented the paperless Validation Lifecycle Management System (VLMS) into their plasma donor collection centers.
ValGenesis Successfully Completes SOC 2 Report for the 2nd Consecutive Year
05/10/2016
As a widely recognized exam, the SOC 2 examination indicates that a service organization has been through an evaluation of their control activities as they relate to the applicable Trust Services Principles and Criteria.
April
Global Medical Device Manufacturer Selects ValGenesis VLMS
04/28/2016
The flexibility of ValGenesis’s automated workflow, form designer and process designer platform will make Validation, Risk and Change management processes easier while significantly reducing the time it takes to accomplish these tasks.
ValGenesis Successfully Completes ISO 90012008 Surveillance Audit
04/21/2016
Since 2012, the ValGenesis organization has successfully continued its ISO 9001:2008 certification. In support of its efforts, ValGenesis has leveraged its own validation lifecycle management system platform to dynamically manage its corporate quality management system.
April
ValGenesis Successfully Completes SOC 2 Report under AT Section 101
04/01/2015
ValGenesis Inc, the market leader in enterprise Validation Lifecycle Management Software solutions, announced today that it has completed its Service Organization Controls 2 (SOC 2) examination under AT Section 101, Attest Engagements (AICPA, Professional Standards) for the period of January 1st 2014 through December 31st 2014.
December
Varian Medical Systems Implements ValGenesis Cloud Solution
12/08/2014
ValGenesis provides a holistic view of the change control process and associated validation deliverables. All of the validation activities are accessible in real-time from a convenient dashboard within ValGenesis, which provides a direct line to validation tasks, inventory, work in progress, calendars, projects, reports, and a 360-degree view of GxP systems and assets by site.
June
ScinoPharm goes live with ValGenesis VLMS 3.0
06/23/2014
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) announced that ScinoPharm Taiwan Ltd., a manufacturer of potent compound API and finished drug products, has implemented and successfully gone live with the ValGenesis VLMS 3.0 – Validation Lifecycle Management Solution to manage their validation lifecycle processes.
January
Dr. Ajaz Hussain to Serve as an Advisor to ValGenesis, Inc.
01/21/2014
Dr. Hussain will advise ValGenesis’s senior management team to facilitate their efforts towards delivering state-of-the-art ValGenesis VLMS. Specifically his contributions will help to align further evolutions of ValGenesis VLMS to proactively deliver emerging regulatory requirements in the US and Globally.